MyFinsight
Home
Blog
About
Back
Income Statement
Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc (SNDX)
source: myfinsight.com
Net loss
-$49,363K
(31.29%↑ Y/Y)
Product
$54,700K
(91.26%↑ Y/Y)
Collaboration Revenue
$18,088K
(93.29%↑ Y/Y)
Loss from operations
-$39,995K
(42.33%↑ Y/Y)
Total other (expense)
income, net
-$9,368K
(-275.62%↓ Y/Y)
Total revenues
$72,788K
(91.76%↑ Y/Y)
Interest income
$3,746K
(-37.04%↓ Y/Y)
Total operating
expenses
$112,783K
(5.10%↑ Y/Y)
Royalty interest
expense
$12,119K
(54.30%↑ Y/Y)
Convertible note interest
expense
$555K
Other expense
-$438K
(-174.74%↓ Y/Y)
Other interest
expense
$2K
(-50.00%↓ Y/Y)
Research and development
$68,036K
(9.34%↑ Y/Y)
Selling, general and
administrative
$41,539K
(-5.17%↓ Y/Y)
Cost of product sales
$3,208K
(150.82%↑ Y/Y)
Back